Clinical Trial Update: Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment [Phase 2, Phase 3]

View source ↗

Summary

This completed study assessed the glycemic efficacy and renal safety of dapagliflozin in subjects with type 2 diabetes mellitus and moderate renal impairment, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-02-10